Effects of GLP ‐1 receptor agonists on cognitive function in patients with type 2 diabetes: A systematic review and meta‐analysis based on randomized controlled trials

Documenti analoghi

• The effect of GLP ‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis
  di: Yifan Ren, et al.
  Pubblicazione: (2025)
• GLP ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations
  di: Teerapon Dhippayom, et al.
  Pubblicazione: (2025)
• Sex differences in the efficacy of GLP ‐1 receptor agonists: A systematic review and meta‐analysis of cardiovascular and renal outcome trials
  di: Hasan Fareed Siddiqui, et al.
  Pubblicazione: (2025)
• Cardiorenal outcomes and mortality with GLP ‐1 receptor agonists combined with SGLT2 inhibitors in type 2 diabetes: An updated systematic review and meta‐analysis
  di: João Sérgio Neves, et al.
  Pubblicazione: (2025)
• Efficacy of GLP ‐1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled trials
  di: Armando Talavera, et al.
  Pubblicazione: (2025)